Nykode Therapeutics proposes chair of Zealand Pharma to lead own board
The board at Norwegian biotech firm Nykode Therapeutics, which is led by Danish CEO Michael Engsig, has proposed that the current Chairman at Zealand Pharma Martin Nicklasson also chairs the board at Nykode.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
When Norwegian biotech firm Nykode Therapeutics meets for its general assembly on Dec. 22, a new face will join as chairman of the board of directors.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Stockholm wants to become leading life science region
For subscribers
.jpg&w=384&q=75)
